BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
TRAW upcoming catalysts
Traws Pharma, Inc.: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 3 readout(s) and 0 FDA event(s). Subscribe to TRAW (.ics).
Drugs: TRX-100, Letrozole
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|
| No upcoming PDUFA date or AdCom found. |
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2026-12 est. | P2 | Traws Pharma, Inc. TRAW | NCT07371650 This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza | Influenza | active not recruiting | 105 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|
| No FDA decision events in this window. |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2026-11 est. | P2 | Traws Pharma, Inc. TRAW | NCT07503405 Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model | Influenza | not yet recruiting | 165 |
| 2026-02-16 | P2 | Traws Pharma, Inc. TRAW | NCT07157007 Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19 | COVID - 19 | completed | 93 |
| 2026-01 est. | P1/P2 | Traws Pharma, Inc. TRAW | NCT05705505 Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies | Endometrioid Endometrial Cancer | unknown | 60 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.